Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Central European Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT00286819
First received: February 3, 2006
Last updated: May 15, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given